← FDA DRUG APPROVALS

FDA ANDA · ANDA208212

VILAZODONE HYDROCHLORIDE

Sponsor: TEVA PHARMS USA

APPLICATION
ANDA208212
TYPE
ANDA
ORIGINAL APPROVAL
2019-09-30
LATEST ACTION
2025-01-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

VILAZODONE HYDROCHLORIDEPrescription
VILAZODONE HYDROCHLORIDE 40MG · TABLET · ORAL
VILAZODONE HYDROCHLORIDEPrescription
VILAZODONE HYDROCHLORIDE 10MG · TABLET · ORAL
VILAZODONE HYDROCHLORIDEPrescription
VILAZODONE HYDROCHLORIDE 20MG · TABLET · ORAL

Approval history

2025-01-14Labeling · Supplement 8 · standardAP
2023-06-07Labeling · Supplement 3 · standardAP
2019-09-30UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →